MedTrace Logo

Sole-Therapy Treatment of Atrial Fibrillation

NCT00566176 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2013-02-05

No results posted yet for this study

Summary

RESTORE SR II is a feasibility study on the minimally invasive use of the AtriCure Bipolar System for PV Isolation on a beating heart for the treatment of all types of atrial fibrillation in a sole therapy operation (not concomitant to another cardiac operation).

Conditions

Interventions

DEVICE

Surgical Ablation using the AtriCure Bipolar System

Surgical Ablation using the AtriCure Bipolar System

Sponsors & Collaborators

  • AtriCure, Inc.

    lead INDUSTRY

Principal Investigators

  • Warren Jackman, MD · University of Oklamhoma Cardiac Arrythmia Research Institute

  • James Edgerton, MD · Medical City Hospital/Cardio Pulmonary Research Science and Technology Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2007-12-31
Completion
2017-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00566176 on ClinicalTrials.gov